Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Octapharma has received approval from the US Food and Drug Administration (FDA) for a new 2-gram (g) formulation of Fibryga ...

Novo Nordisk shares inch higher as the pharma giant announces an oral Wegovy partnership with Amazon Pharmacy. Here’s why NVO ...

Proposal aims to build a database of bulk drug traders, improve traceability of imported raw materials, over 70% of which ...

The move would dismantle the existing system under which bulk drugs and finished formulations operate under a common licence ...

The majority of primary care physicians report that drug shortages affect the quality of patient care and increase ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

WELT introduces a new treatment paradigm that unites drug + timing + patient‑specific real‑world data into a continuously adaptive therapeutic loop. The AI learns from each individual's patterns and ...

Shardul Nautiyal, Mumbai Thursday, January 8, 2026, 08:00 Hrs [IST] ...

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

Renexxion Ireland Limited ('Renexxion'), a private biopharmaceutical company focused on advancing new therapies for patients ...